Lakewood-Amedex Biotherapeutics, Inc.

US$0.39As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LABTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (402.84%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$0.915M
ROIC (166.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.377
(2.45%)
(97.40%)
Sell 0|7|12|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
23.22%
20.71%
36.38%
27.70%
Revenue$M
0.046
0.046
0.048
0.048
3.51%
0.28%
5.47%
3.37%
Peers (US$0.915M)
Cap (US$)
PE
1.130M
—
0.857M
—
Capital
TTM
5Y
10Y
Leveragex
2.016
0.223
0.208
EBIT/Intx
2.878
0.165
0.159
Own earn%
(129.43)
52.89
80.63
Sh yield%
40.41
64.26
58.39
Owners
Insiders/Inst%
6.39
27.13
Short interest%
4.75
SBC / revenue%
2.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
7–11
$1 testx
—
Incr. ROIC%
4